Moxie Dwight
- SEC CIK
- 0001803375
No open-market purchases or sales filed in the past year.
Current role at each company
- RVNC Revance Therapeutics, Inc.CLO & GCas of Feb 6, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Moxie Dwight as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2024 (view filing) | Mar 18 | 1 day | Moxie DwightCLO & GC | SSale | −8.13K | $5.04 | −$41.0K | −5.6%137.8K after | |
| Sep 7, 2023 (view filing) | Sep 5-6 | 2 days | Moxie DwightSVP, GC & Secretary | SSale | −34.9K | $17.57 | −$612.5K | −44.2%44.1K after | 2 lots10b5-1 |
| May 16, 2023 (view filing) | May 15 | 1 day | Moxie DwightSVP, GC & Secretary | SSale | −21.4K | $34.55 | −$739.4K | −23.6%69.2K after | |
| Mar 9, 2023 (view filing) | Mar 9 | Same day | Moxie DwightSVP, GC & Secretary | SSale | −18.5K | $31.59 | −$584.3K | −25.0%55.5K after | |
| Sep 16, 2022 (view filing) | Sep 14 | 2 days | Moxie DwightSVP, GC & Secretary | SSale | −11.0K | $27.07 | −$297.8K | −25.8%31.7K after | |
| Sep 28, 2021 (view filing) | Sep 27 | 1 day | Moxie DwightSVP, GC & Secretary | SSale | −1.68K | $30.00 | −$50.3K | −3.4%47.8K after |